100 related articles for article (PubMed ID: 8199046)
1. Serum macrophage colony-stimulating factor (M-CSF) levels correlate with clinical response to interferon-alpha in patients with early-stage B-CLL.
Jewell AP; Yong KL; Worman CP; Tsakona CP; Giles FJ; Goldstone AH
Br J Haematol; 1994 Feb; 86(2):441-3. PubMed ID: 8199046
[TBL] [Abstract][Full Text] [Related]
2. Favorable response of early stage B CLL patients to treatment with IFN-alpha 2.
Ziegler-Heitbrock HW; Schlag R; Flieger D; Thiel E
Blood; 1989 May; 73(6):1426-30. PubMed ID: 2713486
[TBL] [Abstract][Full Text] [Related]
3. Recombinant interferon alfa 2a in the treatment of patients with early stage B chronic lymphocytic leukaemia.
McSweeney EN; Giles FJ; Worman CP; Jewel AP; Tsakona CP; Hoffbrand AV; Mehta AB; Newland AC; Cawley JC; Galvani D
Br J Haematol; 1993 Sep; 85(1):77-83. PubMed ID: 8251412
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of TNF, IL-6 and sCD23 correlate with changes in lymphocyte count in patients with B-cell chronic lymphocytic leukaemia receiving interferon-alpha therapy.
Jewell AP; Worman CP; Giles FJ; Goldstone AH
Leuk Lymphoma; 1997 Jan; 24(3-4):327-33. PubMed ID: 9156662
[TBL] [Abstract][Full Text] [Related]
5. Interferon alfa-2b therapy in untreated early stage, B-chronic lymphocytic leukaemia patients: one-year follow-up.
Boussiotis VA; Pangalis GA
Br J Haematol; 1991 Oct; 79 Suppl 1():30-3. PubMed ID: 1931705
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of 2',5 oligoadenylate synthetase during interferon therapy in patients with B-cell chronic lymphocytic leukemia.
Musolino C; Grosso P; Alonci A; Allegra A; Orlando A; Cincotta M; Buda G; Squadrito G
Am J Hematol; 1993 May; 43(1):1-4. PubMed ID: 8317456
[TBL] [Abstract][Full Text] [Related]
7. Macrophage colony stimulating factor involvement in uremic patients.
Le Meur Y; Fixe P; Aldigier JC; Leroux-Robert C; Praloran V
Kidney Int; 1996 Sep; 50(3):1007-12. PubMed ID: 8872977
[TBL] [Abstract][Full Text] [Related]
8. Differentiation and activation antigens on blood mononuclear cells in lymphocytic leukemia before and during IFN-alpha 2B therapy.
Demeter J; Paloczi K; Bibok G; Lehoczky D
Leukemia; 1992; 6 Suppl 3():41S-45S. PubMed ID: 1602826
[TBL] [Abstract][Full Text] [Related]
9. Low-dose "natural" alpha-interferon in B-cell derived chronic lymphocytic leukemia.
Pozzato G; Franzin F; Moretti M; Tulissi P; Pecorari P; Melato M; Zacchi T; Evangelisti P; Campanacci L
Haematologica; 1992; 77(5):413-7. PubMed ID: 1483591
[TBL] [Abstract][Full Text] [Related]
10. Treatment strategies for early-stage chronic lymphocytic leukemia: can interferon-inducible MxA protein and tumor necrosis factor play a role as predictive markers for response to interferon therapy?
Bezares F; Kohan S; Sacerdote de Lustig E; Farías E; Murro H; Horisberger MA
J Interferon Cytokine Res; 1996 Jul; 16(7):501-5. PubMed ID: 8836914
[TBL] [Abstract][Full Text] [Related]
11. Interferon-alpha 2b (IFN alpha) for early-phase chronic lymphocytic leukaemia with high risk for disease progression: results of a randomized multicentre study.
Langenmayer I; Nerl C; Knauf W; Dempster S; Hallek M; Adorf D; Dietzfelbinger H; Busch R; Ziegler-Heitbrock HW; Thiel E; Emmerich B
Br J Haematol; 1996 Aug; 94(2):362-9. PubMed ID: 8759897
[TBL] [Abstract][Full Text] [Related]
12. Treatment of early stage B-cell chronic lymphocytic leukemia with alpha-interferon. Gruppo per lo Studio e la Cura delle Gammapatie Monoclonali.
Haematologica; 1991; 76(4):298-304. PubMed ID: 1794737
[TBL] [Abstract][Full Text] [Related]
13. Effects of interferon-alpha on peripheral neutrophil counts and serum granulocyte colony-stimulating factor levels in chronic hepatitis C patients.
Fukuda A; Kobayashi H; Teramura K; Yoshimoto S; Ohsawa N
Cytokines Cell Mol Ther; 2000 Sep; 6(3):149-54. PubMed ID: 11140884
[TBL] [Abstract][Full Text] [Related]
14. Changes of serum neopterin, beta 2-microglobulin and interferon-gamma in patients with chronic hepatitis C treated with interferon-alpha 2b.
Fuchs D; Norkrans G; Wejstal R; Reibnegger G; Weiss G; Weiland O; Schvarcz R; Fryden A; Wachter H
Eur J Med; 1992; 1(4):196-200. PubMed ID: 1341444
[TBL] [Abstract][Full Text] [Related]
15. IL-6 is a survival prognostic factor in renal cell carcinoma.
Thiounn N; Pages F; Flam T; Tartour E; Mosseri V; Zerbib M; Beuzeboc P; Deneux L; Fridman WH; Debré B
Immunol Lett; 1997 Jul; 58(2):121-4. PubMed ID: 9271323
[TBL] [Abstract][Full Text] [Related]
16. Interferon-alpha up-regulates bcl-2 expression and protects B-CLL cells from apoptosis in vitro and in vivo.
Jewell AP; Worman CP; Lydyard PM; Yong KL; Giles FJ; Goldstone AH
Br J Haematol; 1994 Oct; 88(2):268-74. PubMed ID: 7803269
[TBL] [Abstract][Full Text] [Related]
17. Phase I trial of recombinant macrophage colony-stimulating factor and recombinant gamma-interferon: toxicity, monocytosis, and clinical effects.
Weiner LM; Li W; Holmes M; Catalano RB; Dovnarsky M; Padavic K; Alpaugh RK
Cancer Res; 1994 Aug; 54(15):4084-90. PubMed ID: 8033141
[TBL] [Abstract][Full Text] [Related]
18. [Changes of neopterin in cerebrospinal fluid and serum in children with meningitis].
Kawakami Y; Fukunaga Y; Hashimoto K
No To Hattatsu; 1996 Jan; 28(1):23-9. PubMed ID: 8579853
[TBL] [Abstract][Full Text] [Related]
19. [Interferon alfa-2B in chronic lymphatic leukemia of the B-cell type].
Schlag R; Flieger D; Ziegler-Heitbrock HW; Hill W; Emmerich B; Thiel E
Dtsch Med Wochenschr; 1990 Jul; 115(28-29):1088-95. PubMed ID: 2373039
[TBL] [Abstract][Full Text] [Related]
20. Transient regression in lymphocyte count in B-cell chronic lymphocytic leukemia after viral infection.
Shirono K; Ikebe M; Inada T; Tsuda H
Acta Haematol; 1995; 93(1):46-9. PubMed ID: 7725850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
